G01N 33/537
With separation of immune complex from unbound antigen or antibody
Official title: with separation of immune complex from unbound antigen or antibody
G01N33/537 (With separation of immune complex from unbound antigen or antibody) appears on 578 US grants and 516 published applications in this corpus.
Search patents in G01N- Granted patents
- 578
- Published applications
- 516
- Assignees
- 421
- Inventors
- 1,499
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 4 | 0 |
| 1978 | 11 | 0 |
| 1979 | 11 | 0 |
| 1980 | 5 | 0 |
| 1981 | 14 | 0 |
| 1982 | 11 | 0 |
| 1983 | 1 | 0 |
| 1984 | 9 | 0 |
| 1985 | 7 | 0 |
| 1986 | 3 | 0 |
| 1987 | 8 | 0 |
| 1988 | 11 | 0 |
| 1989 | 9 | 0 |
| 1990 | 15 | 0 |
| 1991 | 8 | 0 |
| 1992 | 9 | 0 |
| 1993 | 12 | 0 |
| 1994 | 8 | 0 |
| 1995 | 13 | 0 |
| 1996 | 15 | 0 |
| 1997 | 14 | 0 |
| 1998 | 18 | 0 |
| 1999 | 14 | 0 |
| 2000 | 9 | 0 |
| 2001 | 10 | 6 |
| 2002 | 9 | 15 |
| 2003 | 16 | 16 |
| 2004 | 7 | 15 |
| 2005 | 6 | 16 |
| 2006 | 6 | 10 |
| 2007 | 7 | 10 |
| 2008 | 5 | 12 |
| 2009 | 6 | 15 |
| 2010 | 6 | 18 |
| 2011 | 6 | 18 |
| 2012 | 10 | 22 |
| 2013 | 13 | 19 |
| 2014 | 12 | 17 |
| 2015 | 15 | 17 |
| 2016 | 10 | 19 |
| 2017 | 16 | 18 |
| 2018 | 18 | 33 |
| 2019 | 22 | 53 |
| 2020 | 17 | 40 |
| 2021 | 25 | 40 |
| 2022 | 24 | 22 |
| 2023 | 22 | 23 |
| 2024 | 20 | 14 |
| 2025 | 20 | 19 |
| 2026 | 5 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Automated liquid-phase immunoassay apparatus and method therefor9 Jun 2026US 12,650,426 B2Boditech Med Inc.
- Recombinant full-length single chain immunoglobulins19 May 2026US 12,630,634 B2Etablissement Francais Du Sang
- Polymeric dyes having a backbone comprising organophosphate units17 Mar 2026US 12,578,342 B2Sony Group Corporation
- Assays for detecting the presence or amount of an anti-drug antibody3 Mar 2026US 12,566,186 B2Genzyme Corporation
- Separating and quantifying unbound target analytes from biological samples20 Jan 2026US 12,528,029 B2ARUP Laboratories, Inc.
- Method and device for estimating amount of tau protein accumulation in subject's brain24 Sep 2026US 2026/0287581 A1National Institutes for Quantum Science and Technology
- Vanishing device for enrichment, retrieval, separation, arrangement of targeted agents and methods of fabrication3 Sep 2026US 2026/0259200 A1Georgia Tech Research Corporation
- Ltbp complex-specific inhibitors of tgf-beta 1 and uses thereof13 Aug 2026US 2026/0234272 A1Scholar Rock, Inc.
- Molecular indexing of proteins by self assembly (mipsa) for efficient proteomic investigations23 Jul 2026US 2026/0209391 A1The Johns Hopkins University
- Compositions, Methods, and Kits for the Isolation of Extracellular Vesicles23 Jul 2026US 2026/0210951 A1Exosome Diagnostics, Inc.
Most cited
By later US patents
- Reverse sandwich immunoassay465US 4,098,876 ACorning Glass Works · 1978
- Automated continuous and random access analytical system248US 5,358,691 AAbbott Laboratories · 1994
- Microplate thermal shift assay for ligand development using 5-(4″dimethylaminophenyl)-2-(4′-phenyl)oxazole derivative fluorescent dyes231US 6,569,631 B13-Dimensional Pharmaceuticals, Inc. · 2003
- Scheduling operation of an automated analytical system230US 5,646,049 AAbbott Laboratories · 1997
- Use of retentate chromatography to generate difference maps229US 6,225,047 B1Ciphergen Biosystems, Inc. · 2001